Skip to content
TickerMagic

Omaxe Limited

OMAXENSEReal Estate
₹99.31
+0.70 (+0.71%) · EOD 2026-11-20

Our verdict

Strong Sell

Valuation (58/100) does the heavy lifting; financial trend (0/100) is the drag.

ExpensiveHealth FSolvency risk
Quality 5Momentum 40Value 58Trend 0The Spark ↓

Our fair value

Undervalued by 94%
₹192.75up 94.09%
Price ₹99Range ₹65 – ₹208

Buy-below (20% margin of safety): ₹154.2

The bottom line

Omaxe Limited earns a Strong Sell from TickerMagic, with a blended score of 27/100. We put fair value near ₹192.75; at ₹99.31 that leaves roughly 94% upside, so the stock screens undervalued by 94%. The price is about 27% below its 52-week high of ₹136.38 and 55% above the low of ₹64.09. Financial health scores 0/100, in the distress band on the Altman Z-score, with a Piotroski F-score of 4/9. It clears 3 of 10 investability checks, with durability 5, valuation 15 and momentum 40 on our 0–100 scales.

Analysis by Ankit Sharma · TickerMagic's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.

Intrinsic value
Our fair value
₹192.75up 94.09%
Undervalued by 94%
Price ₹99.31Range ₹64.52–₹208.17
Relative multipleslow confidence

With a 20% margin of safety, our buy-below price is ₹154.2. Low-confidence estimate — limited data.

1-year price

EOD · 2026-11-20
1D
up 0.71%
1W
down 3.86%
1M
down 13.31%
3M
down 2.57%
6M
up 32.75%
1Y
—

52-week range

-27.18% from the 52-week high.

Trend check
Below 50-DMA₹107Above 200-DMA₹89

Price above both moving averages reads as an intact uptrend; below both, the trend is against you.

Verdict pillars

Strong Sell27
F
Financial health 0/100
Altman Z -0.02 · Distress zone

Piotroski F-score 4/9 — quality of earnings & balance sheet.

Our scores

Durability5
Valuation15
Momentum40

Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.

Investability checklist

Passed 3 of 10 checks
Each check screens one fundamentals, valuation or trend signal.
  • No data: ROE above 15%
  • No data: Low debt (D/E < 0.5)
  • Fail: Positive free cash flow
  • Fail: Revenue growth > 10%: -36%
  • No data: Earnings growing
  • Fail: Net margin ≥ 10%: -55.6%
  • Fail: Current ratio > 1.5: 0.97
  • Pass: Below our fair value
  • Pass: Margin of safety ≥ 20%
  • Pass: Above 200-day average
  • Fail: Above 50-day average
  • No data: Positive 1-year return
  • Fail: Altman Z in safe zone: Z -0.02
  • Fail: Piotroski ≥ 7: 4/9

Annual financials

Revenue · 2014
₹1,623 Cr
Net profit
₹79 Cr
Margin
5%
2011
2012
2013
2014
Revenue Net profitLatest revenue YoY -22%

Shareholding

  • Promoter77.2%
  • Institutions4.2%
  • Public & other18.6%

Promoter holding via insider stake; institutional via reported holdings.

Key fundamentals

Market cap
₹1,424 Cr
P/E ratio
—
P/B ratio
—
EPS (TTM)
₹-38.1
ROE
—
Debt / Equity
—
Profit margin
-55.6%
Free cash flow
₹-79 Cr
52-week high
₹136.38
-27.18% from high
52-week low
₹64.09
Dividend yield
—
Beta
-0.06
SWOT snapshot

Bull case vs bear case

Bull case

Opportunities

  • Trades ~94% below our estimated fair value.

Bear case

Threats

  • Rich valuation versus sector peers.
  • Balance-sheet stress — Altman Z -0.02.

About Omaxe Limited

Omaxe Limited is an Indian real estate developer operating across residential, commercial, retail, and integrated township projects. Its portfolio encompasses group housing, SCOs, shopping malls, hotels, and office spaces. The company changed its name from Omaxe Construction Limited in June 2006.

Omaxe Limited — frequently asked questions

Is Omaxe Limited a buy, hold or sell?

TickerMagic currently rates Omaxe Limited (OMAXE) a Strong Sell, based on a blended score of 27/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.

What is Omaxe Limited's fair value?

Our blended DCF and relative-valuation model estimates Omaxe Limited's fair value at about ₹192.75, versus a current price of ₹99.31 — roughly 94% upside. On that basis the stock looks undervalued by 94%.

Is Omaxe Limited financially healthy?

Omaxe Limited scores 0/100 on our financial-health model, placing it in the distress band on the Altman Z-score, with a Piotroski F-score of 4/9.

How has Omaxe Limited's share price performed?

Omaxe Limited is down 3% over three months, and last traded at ₹99.31. Past performance doesn't predict future returns.

Our verdict, fair value, financial-health and checklist are TickerMagic's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.